MTANZ board member Aisling Weir explores the history and complexities of medical device regulation in New Zealand. She discusses the challenges and opportunities within the evolving landscape of medical technology and how new legislation - the Medical Products Bill - aims to address these issues. Also, the difficulty of regulating AI in relation to medical devices and what New Zealand could learn from how international regulatory agencies are approaching this.
All content for eHealthTALK NZ is the property of Rebecca McBeth and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
MTANZ board member Aisling Weir explores the history and complexities of medical device regulation in New Zealand. She discusses the challenges and opportunities within the evolving landscape of medical technology and how new legislation - the Medical Products Bill - aims to address these issues. Also, the difficulty of regulating AI in relation to medical devices and what New Zealand could learn from how international regulatory agencies are approaching this.
Harnessing digital tools and behavioural science to improve health outcomes
eHealthTALK NZ
17 minutes
6 months ago
Harnessing digital tools and behavioural science to improve health outcomes
Auckland GP Reza Jarral discusses his research plans after being awarded the prestigious 2025–2026 Harkness Fellowship to travel to the US and investigate how digital health tools and behavioural science can be harnessed to improve health outcomes. He discusses how consumer technologies, such as wearables, health apps, and digital coaches, can drive behaviour change, and his hopes to translate this research into both clinical practice and national policy back in New Zealand.
eHealthTALK NZ
MTANZ board member Aisling Weir explores the history and complexities of medical device regulation in New Zealand. She discusses the challenges and opportunities within the evolving landscape of medical technology and how new legislation - the Medical Products Bill - aims to address these issues. Also, the difficulty of regulating AI in relation to medical devices and what New Zealand could learn from how international regulatory agencies are approaching this.
